Definitive radiation therapy for squamous cell carcinoma of the soft palate.

Journal: Head & Neck
Published:
Abstract

Background: We report the University of Florida experience with soft-palate carcinoma treated with radiotherapy alone or combined with adjuvant chemotherapy and/or neck dissection for residual disease in the neck.

Methods: A total of 145 patients treated with curative intent from 1963 to 2004 were included. Potential follow-up was > or =2 years.

Results: Local control rates at 5 years were: T1, 90%; T2, 91%; T3, 67%; T4, 57%. Nodal control rates at 5 years were: N0, 90%; N1, 82%; N2, 68%; N3, 71%. Ultimate local-regional control rates at 5 years were: stage I, 89%; stage II, 88%; stage III, 96%; stage IVA, 63%; stage IVB, 43%. In multivariate analysis, overall treatment time significantly affected local and ultimate local-regional control, and nodal stage significantly affected overall survival. Overall survival rate at 5 years was 44%. Cause-specific survival rate at 5 years was 73%.

Conclusions: The likelihood of cure after definitive radiotherapy is relatively high and is impacted by disease extent and overall treatment time.

Authors
Bhishamjit Chera, Robert Amdur, Russell Hinerman, Christopher Morris, Douglas Villaret, John Werning, William Mendenhall